More than 580,000 bottles of blood pressure medication are being recalled across the United States due to possible carcinogenic substances, according to a notice from the Food and Drug Administration (FDA).
The recall involves three separate lots of prazosin hydrochloride, a type of alpha-blocking medication, that were distributed by New Jersey-based Teva Pharmaceuticals, because a test result for N-nitroso Prazosin impurity C found that the substance’s levels are above the “acceptable intake limit” under a type of test for carcinogens.
